Tekmira Pharmaceuticals gives up research on Ebola treatment to focus on Hepatitis B

A month ago, the drug company closed enrollment in clinical tests of its TKM-Ebola in Sierra Leone, after a report concluded that the drug had no … Full Article http://j.gs/5sTq

Click here to read full article